|
Dr. Kim Whitten joined the Diffusion team in April 2007 to expand the company’s clinical development capability. Dr. Whitten has a Doctorate in Pharmacy and is a licensed Pharmacist with over 25 years experience in drug development and regulatory affairs. During this time she’s worked in multiple therapeutic areas involving all phases of the global drug-development process. Prior to joining Diffusion Pharmaceuticals, Dr. Whitten held positions ranging from Clinical Monitor to VP/Clinical Development with major pharmaceutical and clinical research organizations, including ICI/AstraZeneca, GlaxoSmithKline, PPD Inc, Charlottesville Medical Research and Kendle International. | 